Yubo International Biotech Limited

Symbol: YBGJ

PNK

0.325

USD

Markedspris i dag

-175.4014
P/E-forhold
-1.8389
PEG Ratio
38.94M
MRK Cap
0.00%
DIV Udbytte

Yubo International Biotech Limited (YBGJ) Årsregnskaber

Q: Hvad er virksomhedens profitmargin?

Virksomhedens profitmargin er .

Download

Årlig Kvartalsvis

Lineær Log

På diagrammet kan du se standardtallene i dynamik for Yubo International Biotech Limited (YBGJ). Virksomhedens omsætning viser gennemsnittet af NaN M, som er NaN % gowth. Den gennemsnitlige bruttofortjeneste for hele perioden er NaN M, som er NaN %. Den gennemsnitlige bruttofortjeneste er NaN %. Væksten i nettoindkomst for virksomheden sidste år er NaN %, hvilket svarer til NaN % % i gennemsnit for hele virksomhedens historie.,

Årlig Kvartalsvis

10Y 20Y 30Y 40Y

Balance

Når vi dykker ned i den skattemæssige udvikling for Yubo International Biotech Limited, ser vi en gennemsnitlig aktivvækst. Det er interessant, at denne rate ligger på , hvilket afspejler både virksomhedens op- og nedture. Når man sammenligner kvartal for kvartal, justeres dette tal til . Et kig tilbage på det seneste år afslører en samlet aktivændring på NaN. Aktionærværdi, som vist ved den samlede egenkapital, er vurderet til NaN i rapporteringsvalutaen. Ændringen fra år til år i dette aspekt er NaN%.

common:word.in-mln USD Growth	2021	2019	2017	2015	2013	2011	2009	2007	2005	2003
balance-sheet.row.cash-and-short-term-investments	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0.8
balance-sheet.row.short-term-investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.net-receivables	0.3	0.6	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.inventory	0.3	0.2	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-current-assets	0.4	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-current-assets	0.8	1.1	1.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.3	0.8
balance-sheet.row.property-plant-equipment-net	1.4	3.3	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.goodwill	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	0.1	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.goodwill-and-intangible-assets	0.1	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.long-term-investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.tax-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-non-current-assets	0.1	0.2	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-non-current-assets	1.6	3.5	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	2.3	4.6	2.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.3	0.8
balance-sheet.row.account-payables	0.5	0.3	0.1	0.3	0.3	0.3	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.3	0.3	0.3	0.2	0.3	0.4	0.4
balance-sheet.row.short-term-debt	0.4	0.8	0.3	1.3	1.2	0.9	0.8	0.7	0.6	0.5	0.4	0.3	0.2	0.2	0.1	0	0	0	0	0
balance-sheet.row.tax-payables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.long-term-debt-total	0.4	1.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Deferred Revenue Non Current	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	1.1	1.3	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3
balance-sheet.row.total-non-current-liabilities	0.4	1.9	0	1.6	1.5	1.3	1.2	1.1	1	0.9	0.8	0.7	0.6	0.5	0.4	0.3	0.2	0.3	0.4	0
balance-sheet.row.other-liabilities	0	0	0	-1.6	-1.5	-1.3	-1.2	-1.1	-1	-0.9	-0.8	-0.7	-0.6	-0.5	-0.4	-0.3	-0.2	-0.3	-0.4	0
balance-sheet.row.capital-lease-obligations	0.8	2.7	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	2.9	4.7	1.3	1.7	1.5	1.4	1.3	1.1	1	0.9	0.8	0.7	0.6	0.5	0.4	0.3	0.3	0.3	0.5	0.8
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1
balance-sheet.row.retained-earnings	-3.7	-2.5	-0.9	-29	-28.8	-28.7	-28.4	-28.3	-28.2	-28.1	-28	-27.9	-27.8	-27.7	-27.6	-27.5	-27.4	-27.3	-27.2	-27
balance-sheet.row.accumulated-other-comprehensive-income-loss	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	2.9	2.1	2	27.3	27.3	27.3	27.2	27.2	27.2	27.2	27.2	27.2	27.2	27.2	27.2	27.2	27.1	26.9	26.9	26.9
balance-sheet.row.total-stockholders-equity	-0.6	-0.1	1.2	-1.7	-1.5	-1.4	-1.3	-1.1	-1	-0.9	-0.8	-0.7	-0.6	-0.5	-0.4	-0.3	-0.2	-0.3	-0.2	0
balance-sheet.row.total-liabilities-and-stockholders-equity	2.3	4.6	2.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.3	0.8
balance-sheet.row.minority-interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-equity	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-debt	0.8	2.7	0.3	1.3	1.2	0.9	0.8	0.7	0.6	0.5	0.4	0.3	0.2	0.2	0.1	0	0	0	0	0
balance-sheet.row.net-debt	0.8	2.7	-1.1	1.3	1.1	0.9	0.8	0.7	0.6	0.5	0.4	0.3	0.2	0.2	0.1	0	0	0	-0.3	-0.8

Pengestrømsopgørelse

Det økonomiske landskab for Yubo International Biotech Limited har set en bemærkelsesværdig ændring i det frie cash flow i løbet af den sidste periode, hvilket udviser et skift på NaN. Virksomheden udvidede for nylig sin aktiekapital ved at udstede NaN, hvilket markerer en forskel på NaN i forhold til det foregående år. Virksomhedens investeringsaktiviteter resulterede i et nettokasseforbrug på NaN i rapporteringsvalutaen. Dette er en forskydning på NaN fra året før. I samme periode har virksomheden registreret NaN, NaN og NaN, som er væsentlige for forståelsen af virksomhedens investerings- og afdragsstrategier. Virksomhedens finansieringsaktiviteter førte til et nettokasseforbrug på NaN, med en forskel fra år til år på NaN. Desuden afsatte virksomheden NaN til udbetaling af udbytte til sine aktionærer. Samtidig foretog virksomheden andre finansielle manøvrer, kaldet NaN, som også påvirkede pengestrømmen betydeligt i denne periode. Disse komponenter tegner tilsammen et omfattende billede af virksomhedens økonomiske status og strategiske tilgang til likviditetsstyring.

common:word.in-mln USD Growth	2021	2019	2017	2015	2013	2011	2009	2007	2005	2003
cash-flows.row.net-income	-1.2	-1.5	-0.7	-0.1	-0.1	-0.2	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	-101	-0.2	-3
cash-flows.row.depreciation-and-amortization	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.deferred-income-tax	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	1.2	0.5	0.8	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	0.1	-0.1	-0.2	0.1
cash-flows.row.account-receivables	0.1	-0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	-0.2	-0.1	-0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.account-payables	0.3	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	1	0.6	0.8	-0.3	-0.2	-0.3	-0.2	-0.2	-0.2	-0.2	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	0.1	-0.1	-0.2	0.1
cash-flows.row.other-non-cash-items	0	0	0	0.3	0.2	0.3	0.2	0.2	0.2	0.2	0.1	0.2	0.1	0.2	0.1	0.2	-0.1	100.9	-0.1	0.7
cash-flows.row.net-cash-provided-by-operating-activities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	0	-0.6	-0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.acquisitions-net	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.purchases-of-investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.sales-maturities-of-investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-investing-activites	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-0.1
cash-flows.row.net-cash-used-for-investing-activites	0	-0.6	-0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-0.1
cash-flows.row.debt-repayment	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-issued	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0
cash-flows.row.common-stock-repurchased	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-financing-activites	0	0.1	0.6	0	0.1	0	0.1	0.1	0	0	0	0.1	0.1	0	0	0	-0.1	0	0	0
cash-flows.row.net-cash-used-provided-by-financing-activities	0	0.1	1.4	0	0.1	0	0.1	0.1	0	0	0	0.1	0.1	0	0	0	0.1	0	0	0
cash-flows.row.effect-of-forex-changes-on-cash	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.net-change-in-cash	0	-1.4	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-0.2	-0.5	-2.3
cash-flows.row.cash-at-end-of-period	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0.8
cash-flows.row.cash-at-beginning-of-period	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0.8	3.1
cash-flows.row.operating-cash-flow	0.1	-1	0.1	0	-0.1	-0.1	-0.1	-0.1	0	0	0	0	0	0	0	-0.1	-0.1	-0.2	-0.5	-2.3
cash-flows.row.capital-expenditure	0	-0.6	-0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.free-cash-flow	0	-1.6	0	0	-0.1	-0.1	-0.1	-0.1	0	0	0	0	0	0	0	-0.1	-0.1	-0.2	-0.5	-2.3

Resultatopgørelse række

Yubo International Biotech Limiteds omsætning oplevede en ændring på NaN% sammenlignet med den foregående periode. Bruttofortjenesten for YBGJ rapporteres til at være NaN. Virksomhedens driftsomkostninger er NaN og viser en ændring på NaN% fra sidste år. Udgifterne til afskrivninger er NaN, hvilket er en ændring på NaN% fra sidste regnskabsperiode. Driftsudgifterne rapporteres at være NaN, hvilket viser en NaN% ændring fra år til år. Salgs- og marketingomkostninger er NaN, hvilket er en ændring på NaN% sammenlignet med året før. EBITDA baseret på de seneste tal er NaN, hvilket repræsenterer en NaN% vækst i forhold til året før. Driftsindtægterne er NaN, som viser en ændring på NaN% sammenlignet med året før. Ændringen i nettoindkomsten er NaN%. Nettoindkomsten for det sidste år var NaN.

common:word.in-mln USD Growth	2021	2019	2017	2015	2013	2011	2009	2007	2005	2003
income-statement-row.row.total-revenue	0.1	1.2	1.4	0	0	0	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.cost-of-revenue	0.1	0.4	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.gross-profit	0.1	0.8	1.2	0	0	0	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	0.2	0.9	0.8	-0.1	-0.1	0	0	-0.1	-0.1	-0.1	0	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	-101	-0.3	-4
income-statement-row.row.operating-expenses	1.3	2.4	2	0	-0.1	0.1	0.1	-0.1	-0.1	-0.1	0	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	-101	-0.2	-3
income-statement-row.row.cost-and-expenses	1.3	2.8	2.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	102	0.2	3.1
income-statement-row.row.interest-income	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.interest-expense	0	427	-0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	0	0	0	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	0	0	0	0	0	0.1	0	0.1	71	0.2	-0.2
income-statement-row.row.ebitda-ratio-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	0.2	0.9	0.8	-0.1	-0.1	0	0	-0.1	-0.1	-0.1	0	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	-101	-0.3	-4
income-statement-row.row.total-operating-expenses	0	0	0	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	0	0	0	0	0	0.1	0	0.1	71	0.2	-0.2
income-statement-row.row.interest-expense	0	427	-0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.depreciation-and-amortization	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.ebitda-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	-1.2	-1.5	-0.7	0	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	0	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	-101	-0.2	-3
income-statement-row.row.income-before-tax	-1.2	-1.5	-0.7	-0.1	-0.1	-0.2	-0.1	-0.1	-0.1	-0.1	0	0	0	0	0	0	0	-30	0	-3.2
income-statement-row.row.income-tax-expense	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0	0	0.1	71	0.2	-0.2
income-statement-row.row.net-income	-1.2	-1.5	-0.7	-0.1	-0.1	-0.2	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	-0.1	0	-0.1	-0.1	-101	-0.2	-3